Skip to Main content Skip to Navigation
Journal articles

Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease.

Abstract : RATIONALE: Although chronic obstructive pulmonary disease is the first indication for lung transplantation, the benefit of the procedure in terms of survival remains debated. OBJECTIVES: To estimate the determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. METHODS: Using information from the United Network for Organ Sharing database on 8,182 patients, we developed an approach based on numerical simulations to estimate the survival effect of lung transplantation. MEASUREMENTS AND MAIN RESULTS: The main outcome measure was the difference between median survival with transplantation and that without transplantation measured from time of transplant list registration. Survival benefit was greater with double than with single lung transplantation (mean difference, 307 d [95% confidence interval, 217-523]). With double lung transplantation, 44.6% of patients would gain 1 year or more, 29.4% would gain or lose less than 1 year, and 26% would lose 1 year or more. Major determinants of the survival effect of transplantation were systolic pulmonary artery pressure, FEV(1), body mass index, exercise capacity, functional status, and the need for continuous mechanical ventilation or oxygen. For instance, 79% of patients with an FEV(1) less than 16% of the predicted value would gain 1 year or more with double lung transplantation as compared with only 11% of patients with an FEV(1) of more than 25%. CONCLUSIONS: We identified several factors associated with the survival benefit of lung transplantation. External validation of our models is required before translating these results into clinical practice.
Document type :
Journal articles
Complete list of metadatas

Cited literature [32 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00282520
Contributor : Catherine Gillet <>
Submitted on : Tuesday, May 27, 2008 - 4:32:18 PM
Last modification on : Wednesday, August 19, 2020 - 11:16:54 AM
Long-term archiving on: : Friday, November 25, 2016 - 10:50:58 PM

Files

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Gabriel Thabut, Philippe Ravaud, Jason Christie, Yves Castier, Michel Fournier, et al.. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease.. American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2008, 177 (10), pp.1156-63. ⟨10.1164/rccm.200708-1283OC⟩. ⟨inserm-00282520⟩

Share

Metrics

Record views

385